Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease.

Bruno Ambrosi; Chiara Dall'Asta; Salvatore Cannavo; Rossella Libe; Teresa Vigo; Paolo Epaminonda; Iacopo Chiodini; Stefano Ferrero; Francesco Trimarchi; Maura Arosio

doi:10.1530/eje.0.1510173

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease.

Identifier:nobleid.org/w1/20260515/BBCC3DF8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BBCC3DF8.svg?ark=w1%2F20260515%2FBBCC3DF8)](https://nobleid.org/work/w1/20260515/BBCC3DF8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease.

Identifier:nobleid.org/w1/20260515/BBCC3DF8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BBCC3DF8.svg?ark=w1%2F20260515%2FBBCC3DF8)](https://nobleid.org/work/w1/20260515/BBCC3DF8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work